Literature DB >> 25114761

Modern medical management of acute ischemic stroke.

Larry B Goldstein1.   

Abstract

The modern management of patients with ischemic stroke begins by having a system in place that organizes the provision of preventive, acute treatment, and rehabilitative services. In the acute setting, initial evaluation is aimed at rapidly establishing a diagnosis by excluding stroke mimics, distinguishing between ischemic and hemorrhagic strokes, and determining if the patient is a candidate for treatment with intravenous tissue plasminogen activator (IV-tPA, alteplase). In some centers, select patients who do not qualify for administration of IV-tPA may be considered for endovascular intervention. General measures include the use of platelet antiaggregants, treatment of fever, blood pressure management, and continuation of statins if the patient has already been taking them. Post-acute evaluation and management is aimed at secondary prevention and optimizing recovery, including recognition and treatment of post-stroke depression.

Entities:  

Keywords:  blood pressure; complications; depression; fever; ischemic stroke; platelet antiaggregants; reperfusion

Mesh:

Substances:

Year:  2014        PMID: 25114761      PMCID: PMC4117327          DOI: 10.14797/mdcj-10-2-99

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN: 1947-6108


  48 in total

1.  Efficacy of intra-arterial fibrinolysis for acute ischemic stroke: meta-analysis of randomized controlled trials.

Authors:  Meng Lee; Keun-Sik Hong; Jeffrey L Saver
Journal:  Stroke       Date:  2010-04-01       Impact factor: 7.914

Review 2.  Part 11: adult stroke: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

Authors:  Edward C Jauch; Brett Cucchiara; Opeolu Adeoye; William Meurer; Jane Brice; Yvonne Yu-Feng Chan; Nina Gentile; Mary Fran Hazinski
Journal:  Circulation       Date:  2010-11-02       Impact factor: 29.690

3.  Residual vessel length on magnetic resonance angiography identifies poor responders to alteplase in acute middle cerebral artery occlusion patients: exploratory analysis of the Japan Alteplase Clinical Trial II.

Authors:  Teruyuki Hirano; Makoto Sasaki; Etsuro Mori; Kazuo Minematsu; Jyoji Nakagawara; Takenori Yamaguchi
Journal:  Stroke       Date:  2010-10-28       Impact factor: 7.914

4.  Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.

Authors:  Kennedy R Lees; Erich Bluhmki; Rüdiger von Kummer; Thomas G Brott; Danilo Toni; James C Grotta; Gregory W Albers; Markku Kaste; John R Marler; Scott A Hamilton; Barbara C Tilley; Stephen M Davis; Geoffrey A Donnan; Werner Hacke; Kathryn Allen; Jochen Mau; Dieter Meier; Gregory del Zoppo; D A De Silva; K S Butcher; M W Parsons; P A Barber; C Levi; C Bladin; G Byrnes
Journal:  Lancet       Date:  2010-05-15       Impact factor: 79.321

5.  Outcomes after ischemic stroke for hospitals with and without Joint Commission-certified primary stroke centers.

Authors:  J H Lichtman; S B Jones; Y Wang; E Watanabe; E Leifheit-Limson; L B Goldstein
Journal:  Neurology       Date:  2011-05-04       Impact factor: 9.910

6.  Evidence-based guideline: The role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Authors:  P D Schellinger; R N Bryan; L R Caplan; J A Detre; R R Edelman; C Jaigobin; C S Kidwell; J P Mohr; M Sloan; A G Sorensen; S Warach
Journal:  Neurology       Date:  2010-07-13       Impact factor: 9.910

7.  Association between stroke center hospitalization for acute ischemic stroke and mortality.

Authors:  Ying Xian; Robert G Holloway; Paul S Chan; Katia Noyes; Manish N Shah; Henry H Ting; Andre R Chappel; Eric D Peterson; Bruce Friedman
Journal:  JAMA       Date:  2011-01-26       Impact factor: 56.272

8.  Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association.

Authors:  Karen L Furie; Scott E Kasner; Robert J Adams; Gregory W Albers; Ruth L Bush; Susan C Fagan; Jonathan L Halperin; S Claiborne Johnston; Irene Katzan; Walter N Kernan; Pamela H Mitchell; Bruce Ovbiagele; Yuko Y Palesch; Ralph L Sacco; Lee H Schwamm; Sylvia Wassertheil-Smoller; Tanya N Turan; Deidre Wentworth
Journal:  Stroke       Date:  2010-10-21       Impact factor: 7.914

9.  Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial.

Authors:  François Chollet; Jean Tardy; Jean-François Albucher; Claire Thalamas; Emilie Berard; Catherine Lamy; Yannick Bejot; Sandrine Deltour; Assia Jaillard; Philippe Niclot; Benoit Guillon; Thierry Moulin; Philippe Marque; Jérémie Pariente; Catherine Arnaud; Isabelle Loubinoux
Journal:  Lancet Neurol       Date:  2011-01-07       Impact factor: 44.182

10.  Fever is associated with doubling of odds of short-term mortality in ischemic stroke: an updated meta-analysis.

Authors:  Kameshwar Prasad; P R Krishnan
Journal:  Acta Neurol Scand       Date:  2010-12       Impact factor: 3.209

View more
  8 in total

Review 1.  Targeting therapeutics across the blood brain barrier (BBB), prerequisite towards thrombolytic therapy for cerebrovascular disorders-an overview and advancements.

Authors:  K K Pulicherla; Mahendra Kumar Verma
Journal:  AAPS PharmSciTech       Date:  2015-01-23       Impact factor: 3.246

2.  Neuroprotective effects of combined trimetazidine and progesterone on cerebral reperfusion injury.

Authors:  Vipin Dhote; Avinash Singh Mandloi; Pradeep Kumar Singour; Manisha Kawadkar; Aditya Ganeshpurkar; Manoj P Jadhav
Journal:  Curr Res Pharmacol Drug Discov       Date:  2022-05-06

3.  Noscapine alleviates cerebral damage in ischemia-reperfusion injury in rats.

Authors:  Manisha Kawadkar; Avinash S Mandloi; Vidhu Saxena; Chetana Tamadaddi; Chandan Sahi; Vipin V Dhote
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-10-27       Impact factor: 3.000

4.  Advanced Age and Higher National Institutes of Health Stroke Scale Score as Predictors of Poor Outcome in Ischemic Stroke Patients Treated with Alteplase: A Study from a Tertiary Care Centre in Rural North-west India.

Authors:  Amit Bhardwaj; Girish Sharma; Sunil Kumar Raina; Ashish Sharma; Monica Angra
Journal:  J Neurosci Rural Pract       Date:  2017 Apr-Jun

Review 5.  Stroke Management: An Emerging Role of Nanotechnology.

Authors:  Deepaneeta Sarmah; Jackson Saraf; Harpreet Kaur; Kanta Pravalika; Rakesh Kumar Tekade; Anupom Borah; Kiran Kalia; Kunjan R Dave; Pallab Bhattacharya
Journal:  Micromachines (Basel)       Date:  2017-08-28       Impact factor: 2.891

6.  Salvia miltiorrhiza enhances the survival of mesenchymal stem cells under ischemic conditions.

Authors:  Ran Kim; Seokyeon Lee; Chang Youn Lee; Hwayoung Yun; Hojin Lee; Min Young Lee; Jongmin Kim; Jee-Yeong Jeong; Kyungmin Baek; Woochul Chang
Journal:  J Pharm Pharmacol       Date:  2018-06-25       Impact factor: 3.765

7.  miR-19a/b-3p promotes inflammation during cerebral ischemia/reperfusion injury via SIRT1/FoxO3/SPHK1 pathway.

Authors:  Feng Zhou; Yu-Kai Wang; Cheng-Guo Zhang; Bing-Yi Wu
Journal:  J Neuroinflammation       Date:  2021-05-29       Impact factor: 8.322

8.  Exploring the Essential Stroke Care Structures in Tertiary Healthcare Facilities in Rivers State, Nigeria.

Authors:  Osborne Ikechuckwu Osuegbu; Foluke Olukemi Adeniji; Golden Chukwuemeka Owhonda; Rogers Bariture Kanee; Eric Osamudiamwen Aigbogun
Journal:  Inquiry       Date:  2022 Jan-Dec       Impact factor: 1.730

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.